Dr. Geethanjali Bandla, MD

Dr. Bandla practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Bandla's NPI, 1336335108, was assigned on September 14, 2007. Dr. Bandla holds North Carolina license 2013-01823.

Dr. Bandla's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Bandla's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Regional Hospital. Dmand AI also links Dr. Bandla to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bandla practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bandla's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Bandla's licenses on file in 2 states: North Carolina and Connecticut.

CMS data shows 403 Medicare services from Dr. Bandla across 4 procedure codes in 2024, for 159 Medicare patients. Medicare paid $32,719 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 159 Medicare patients who saw Dr. Bandla in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bandla's median patient age at 72, with 52% women.

In 2024, Dr. Bandla wrote 244 Medicare Part D claims for 91 patients. 88% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $90 in total drug cost. In 2023, CMS named 35 claims across 3 drugs.

Dr. Bandla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Dr. Bandla from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. Merck Sharp & Dohme Corporation paid the most, $60.